Discontinuous Echocardiographic Subcostal Cardiac Output Measurement
Recruiting · NCT07177391 · Observational (researchers observe without assigning treatment) · Lead sponsor: University Hospital, Rouen
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Cardiac output (CO) monitoring is recommended for the most serious and multiple-failure patients in critical care and allows the diagnosis of acute circulatory failure as well as its etiology and also allows the monitoring of treatments. However, although allowing an adaptation of hemodynamic treatments and being integrated into a therapeutic personalization approach in situations of acute circulatory failure, the measurement of CO is conditioned by the availability of devices, by their sometimes problematic invasiveness, as well as their cost. In addition, the discontinuous measurement of CO by echocardiography is made difficult in the context of resuscitation with patients who are less mobilizable and less echogenic.
Who can take part
Inclusion criteria
- Adult patient (Age ≥ 18 years)
- Patient admitted to the intensive care unit at Rouen University Hospital.
- Transthoracic echocardiography (TTE) is required upon admission or during the patient's stay for diagnostic assessment and/or therapeutic monitoring.
Exclusion criteria
- Person deprived of liberty by an administrative or judicial decision or person placed under judicial protection/guardianship or curatorship
- Patient not affiliated with the social security system
- Refusal by the patient or trusted person if the patient is incapable of expressing consent
- Pregnant woman
- Dying patient
Where it is running
1 location listed.
- University Rouen Hospital - Rouen, France